SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-047559
Filing Date
2024-04-24
Accepted
2024-04-24 16:01:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A srpt_def_a14a_notice_202.htm DEFA14A 11070
2 GRAPHIC img173249753_0.jpg GRAPHIC 402410
3 GRAPHIC img173249753_1.jpg GRAPHIC 410008
  Complete submission text file 0000950170-24-047559.txt   1131072
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14895 | Film No.: 24870483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)